Amyris and DSM close US$50M strategic transaction on farnesene supply

The deal licenses DSM rights to assume the supply of farnesene to Givaudan

Related Articles

FormattedPicture

FOOD RESEARCH

27 Jul 2021 --- Global nutrition access is a function of acceptability (knowledge and acceptance of nutritious foods), affordability and availability. This is according to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Jul 2021 --- Brain-boosting ingredients are rising fast as COVID-19 has put extra stress on consumers’ mental health and well-being. Mood, memory and staying mentally... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

13 Jul 2021 --- Givaudan Active Beauty is unveiling Zanthalene, a scalable natural active ingredient, made by green fractionation. The company says it can provide well-aging... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

28 Jun 2021 --- Adaptogens are flourishing in functional F&B applications as stress and anxiety among consumers have hit new highs due to COVID-19-related... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

02 Jun 2021 --- Two of Biosearch Life’s probiotic strains can now be commercialized in Brazil following approval from the Brazilian Health Regulatory Agency... Read More

trans